35 results on '"Masuda, Noriyuki"'
Search Results
2. Modulation of urinary frequency via type 1 lysophosphatidic acid receptors: Effect of the novel antagonist ASP6432 in conscious rats
3. Effect of ASP2205 fumarate, a novel 5-HT2C receptor agonist, on urethral closure function in rats
4. ASP6432, a type 1 lysophosphatidic acid receptor antagonist, reduces urethral function during urine voiding and improves voiding dysfunction
5. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
6. Novel effect of 2-aminoethoxydiphenylborate through inhibition of calcium sensitization induced by Rho kinase activation in human detrusor smooth muscle
7. Low frequency oscillometry parameters in COPD patients are less variable during inspiration than during expiration
8. Gold cleaning methods for electrochemical detection applications
9. Two Types of Cation Channel Activated by Stimulation of Muscarinic Receptors in Guinea-Pig Urinary Bladder Smooth Muscle
10. Expression of hyperpolarization-activated cyclic nucleotide-gated cation channels in rat dorsal root ganglion neurons innervating urinary bladder
11. Characterization of hyperpolarization-activated current ( Ih) in dorsal root ganglion neurons innervating rat urinary bladder
12. Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
13. Calnexin is a novel sero-diagnostic marker for lung cancer
14. Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib.
15. Nab-paclitaxel plus carboplatin as an effective and safe chemotherapy regimen for pulmonary carcinosarcoma with interstitial lung disease: A case report.
16. Phase I and Pharmacologic Study of Weekly Bolus Topotecan for Advanced Non–Small-Cell Lung Cancer.
17. Endobronchial involvement of mantle cell lymphoma: A case report.
18. Characterization of hyperpolarization-activated current (I h) in dorsal root ganglion neurons innervating rat urinary bladder
19. P2.02-027 A Randomized Phase II Trial of S-1 plus Cisplatin or Docetaxel plus Cisplatin with Concurrent Thoracic Radiotherapy for Stage III NSCLC: TORG1018: Topic: Multimodality Treatment.
20. Phase I/II study of oral TS-1 and gemcitabine in elderly patients with advanced non-small-cell-lung cancer (NSCLS): Thoracic Oncology Research Group Study 0502.
21. Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers.
22. Purification and characterization of NADP-dependent 7β-hydroxysteroid dehydrogenase from Peptostreptococcus productus strain b-52
23. Cardiovascular effects of YM099, a novel K + channel opener, in anesthetized and conscious dogs
24. Activation of Akt involves resistance to NF-κB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cells.
25. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
26. Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung
27. Phase I Results of Vinorelbine With Concurrent Radiotherapy in Elderly Patients With Unresectable, Locally Advanced Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI)
28. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung
29. Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502
30. Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
31. Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case report.
32. Synthesis and pharmacological evaluation of piperidinoalkanoyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents
33. Synthesis and pharmacological evaluation of N-acyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents
34. (±)-2-(3-Piperidyl)-1,2,3,4-tetrahydroisoquinolines as a new class of specific bradycardic agents
35. P2-099How should we exploit TAS-102?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.